Y10S 436/813
Cancer
Y10S436/813 (Cancer) appears on 698 US grants and 124 published applications in this corpus.
Search patents in Y10S- Granted patents
- 698
- Published applications
- 124
- Assignees
- 321
- Inventors
- 1,112
- Latest grant
- 5 Sep 2017
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 2 | 0 |
| 1978 | 2 | 0 |
| 1979 | 6 | 0 |
| 1980 | 6 | 0 |
| 1981 | 4 | 0 |
| 1982 | 1 | 0 |
| 1983 | 5 | 0 |
| 1984 | 22 | 0 |
| 1985 | 13 | 0 |
| 1986 | 18 | 0 |
| 1987 | 27 | 0 |
| 1988 | 32 | 0 |
| 1989 | 38 | 0 |
| 1990 | 28 | 0 |
| 1991 | 32 | 0 |
| 1992 | 24 | 0 |
| 1993 | 26 | 0 |
| 1994 | 26 | 0 |
| 1995 | 36 | 0 |
| 1996 | 33 | 0 |
| 1997 | 65 | 0 |
| 1998 | 46 | 0 |
| 1999 | 36 | 0 |
| 2000 | 25 | 0 |
| 2001 | 24 | 5 |
| 2002 | 16 | 24 |
| 2003 | 11 | 14 |
| 2004 | 10 | 12 |
| 2005 | 8 | 14 |
| 2006 | 8 | 7 |
| 2007 | 11 | 6 |
| 2008 | 12 | 11 |
| 2009 | 10 | 7 |
| 2010 | 9 | 5 |
| 2011 | 8 | 5 |
| 2012 | 3 | 7 |
| 2013 | 5 | 3 |
| 2014 | 3 | 1 |
| 2015 | 4 | 1 |
| 2016 | 0 | 0 |
| 2017 | 3 | 1 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Array-based detection of genetic alterations associated with disease5 Sep 2017US 9,753,035 B2The Regents of the University of California
- Tumour markers4 Jul 2017US 9,696,319 B2OncImmune Ltd.
- Quantitative analyte assay device and method31 Jan 2017US 9,557,329 B2Assurance LLC
- Prostasin partial peptide and anti-prostasin antibody28 Apr 2015US 9,017,957 B2Hitachi Chemical Company, Ltd.
- Genes from 20q13 amplicon and their uses31 Mar 2015US 8,993,251 B2The Hospital for Sick Children
- Quantitative analyte assay device and method3 Jan 2019US 2019/0004040 A1Assurance LLC
- Quantitive analyte assay device and method13 Jul 2017US 2017/0199182 A1Assurance LLC
- Quantitative analyte assay device and method21 May 2015US 2015/0140552 A1Assurance LLC
- Use of biomarkers for detecting ovarian cancer6 Feb 2014US 2014/0038852 A1The Johns Hopkins University
- Methods for diagnosis of myelodysplastic syndromes (mds)1 Aug 2013US 2013/0196346 A1The Trustees of the University of Pennsylvania
Most cited
By later US patents
- Metal chelate conjugated monoclonal antibodies310US 4,472,509 A1984
- Multiepitopic immunometric assay310US 5,011,771 AThe General Hospital Corporation · 1991
- Use of retentate chromatography to generate difference maps229US 6,225,047 B1Ciphergen Biosystems, Inc. · 2001
- Tumor localization and therapy with labeled antibodies to cell surface antigens217US 4,444,744 A1984
- Method for detecting pathological conditions211US 4,981,783 AMontefiore Medical Center · 1991